{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:25:13Z","timestamp":1791221113571,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1038\/ncprheum0355","type":"journal-article","created":{"date-parts":[[2006,11,29]],"date-time":"2006-11-29T18:48:00Z","timestamp":1164826080000},"page":"661-670","source":"Crossref","is-referenced-by-count":177,"title":["Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides"],"prefix":"10.1038","volume":"2","author":[{"given":"Cees GM","family":"Kallenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Heeringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen A","family":"Stegeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncprheum0355_CR1","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/art.1780330802","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG et al. (1990) The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 33: 1065\u20131067","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0355_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC et al. (1994) A nomenclature of systemic vasculitides: the proposal of an international consensus conference. Arthritis Rheum 37: 187\u2013192","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0355_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1056\/NEJMra022694","volume":"349","author":"CM Weyand","year":"2003","unstructured":"Weyand CM and Goronzy JJ (2003) Medium- and large-vessel vasculitis. N Engl J Med 349: 160\u2013169","journal-title":"N Engl J Med"},{"key":"BFncprheum0355_CR4","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1056\/NEJM199711203372106","volume":"337","author":"JC Jennette","year":"1997","unstructured":"Jennette JC and Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 337: 1512\u20131523","journal-title":"N Engl J Med"},{"key":"BFncprheum0355_CR5","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1111\/j.1523-1755.2004.00632.x","volume":"65","author":"M Haas","year":"2004","unstructured":"Haas M and Eustace JA (2004) Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Kidney Int 65: 2145\u20132152","journal-title":"Kidney Int"},{"key":"BFncprheum0355_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ki.1994.239","volume":"46","author":"CGM Kallenberg","year":"1994","unstructured":"Kallenberg CGM et al. (1994) Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 46: 1\u201315","journal-title":"Kidney Int"},{"key":"BFncprheum0355_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/ajcp\/111.4.507","volume":"111","author":"J Savige","year":"1999","unstructured":"Savige J et al. (1999) International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 111: 507\u2013513","journal-title":"Am J Clin Pathol"},{"key":"BFncprheum0355_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.7326\/0003-4819-123-12-199512150-00005","volume":"123","author":"JK Rao","year":"1995","unstructured":"Rao JK et al. (1995) The role of antineutrophil cytoplasmic antibody testing in the diagnosis of Wegener granulomatosis. Ann Intern Med 123: 925\u2013932","journal-title":"Ann Intern Med"},{"key":"BFncprheum0355_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","volume":"53","author":"EC Hagen","year":"1998","unstructured":"Hagen EC et al. (1998) Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC\/BCR project for ANCA assay standardization. Kidney Int 53: 743\u2013753","journal-title":"Kidney Int"},{"key":"BFncprheum0355_CR10","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/art.21250","volume":"52","author":"RA Sinico","year":"2005","unstructured":"Sinico RA et al. (2005) Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg\u2013Strauss syndrome. Arthritis Rheum 52: 2926\u20132935","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0355_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","volume":"143","author":"R Sable-Fourtassou","year":"2005","unstructured":"Sable-Fourtassou R et al. (2005) Antineutrophil cytoplasmic antibodies and the Churg\u2013Strauss syndrome. Ann Intern Med 143: 632\u2013638","journal-title":"Ann Intern Med"},{"key":"BFncprheum0355_CR12","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1002\/art.21253","volume":"52","author":"CGM Kallenberg","year":"2005","unstructured":"Kallenberg CGM (2005) Churg\u2013Strauss syndrome: just one disease entity? Arthritis Rheum 52: 2589\u20132593","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0355_CR13","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1046\/j.1523-1755.2000.00080.x","volume":"57","author":"CF Franssen","year":"2000","unstructured":"Franssen CF et al. (2000) Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int 57: 2195\u20132206","journal-title":"Kidney Int"},{"key":"BFncprheum0355_CR14","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","volume":"43","author":"MM Boomsma","year":"2000","unstructured":"Boomsma MM et al. (2000) Prediction of relapses in Wegener's granulomatosis by measurement of anti-neutrophil cytoplasmic antibody levels: a prospective study. Arthritis Rheum 43: 2025\u20132033","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0355_CR15","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/ndt\/17.12.2077","volume":"17","author":"CA Stegeman","year":"2002","unstructured":"Stegeman CA (2002) Anti-neutrophil cytoplasmic antibody (ANCA) levels directed against proteinase-3 and myeloperoxidase are helpful in predicting disease relapse in ANCA-associated small-vessel vasculitis. Nephrol Dial Transplant 17: 2077\u20132080","journal-title":"Nephrol Dial Transplant"},{"key":"BFncprheum0355_CR16","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","volume":"87","author":"RJ Falk","year":"1990","unstructured":"Falk RJ et al. (1990) Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 87: 4115\u20134119","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncprheum0355_CR17","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood.V86.8.3189.3189","volume":"86","author":"D Reumaux","year":"1995","unstructured":"Reumaux D et al. (1995) Effect of tumor necrosis factor-induced integrin activation on Fc gamma receptor II-mediated signal transduction: relevance for activation of neutrophils by anti-proteinase 3 or anti-myeloperoxidase antibodies. Blood 86: 3189\u20133195","journal-title":"Blood"},{"key":"BFncprheum0355_CR18","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1084\/jem.184.4.1567","volume":"184","author":"F Grimminger","year":"1996","unstructured":"Grimminger F et al. (1996) Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation. J Exp Med 184: 1567\u20131572","journal-title":"J Exp Med"},{"key":"BFncprheum0355_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1189\/jlb.1202611","volume":"74","author":"AA Rarok","year":"2003","unstructured":"Rarok AA et al. (2003) Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol 74: 3\u201315","journal-title":"J Leukoc Biol"},{"key":"BFncprheum0355_CR20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1681\/ASN.V83386","volume":"8","author":"R Kettritz","year":"1997","unstructured":"Kettritz R et al. (1997) Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils. J Am Soc Nephrol 8: 386\u2013394","journal-title":"J Am Soc Nephrol"},{"key":"BFncprheum0355_CR21","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4049\/jimmunol.153.3.1271","volume":"153","author":"AJ Porges","year":"1994","unstructured":"Porges AJ et al. (1994) Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa. J Immunol 153: 1271\u20131280","journal-title":"J Immunol"},{"key":"BFncprheum0355_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/j.1365-2249.1994.tb06137.x","volume":"98","author":"AH Mulder","year":"1994","unstructured":"Mulder AH et al. (1994) Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc RII-dependent process. Clin Exp Immunol 98: 270\u2013278","journal-title":"Clin Exp Immunol"},{"key":"BFncprheum0355_CR23","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.4049\/jimmunol.161.12.6909","volume":"161","author":"M Kocher","year":"1998","unstructured":"Kocher M et al. (1998) Antineutrophil cytoplasmic antibodies preferentially engage Fc gamma RIIIb on human neutrophils. J Immunol 161: 6909\u20136914","journal-title":"J Immunol"},{"key":"BFncprheum0355_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1097\/01.ASN.0000050223.34749.F4","volume":"4","author":"JM Williams","year":"2003","unstructured":"Williams JM et al. (2003) Activation of the Gi heterotrimeric G protein by ANCA IgG F(ab')2 fragments is necessary but not sufficient to stimulate the recruitment of those downstream mediators used by intact ANCA IgG. J Am Soc Nephrol 4: 661\u2013669","journal-title":"J Am Soc Nephrol"},{"key":"BFncprheum0355_CR25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1681\/ASN.V1061224","volume":"10","author":"V Witko-Sarsat","year":"1999","unstructured":"Witko-Sarsat V et al. (1999) A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol 10: 1224\u20131233","journal-title":"J Am Soc Nephrol"},{"key":"BFncprheum0355_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/01.ASN.0000040751.83734.D1","volume":"14","author":"A Schreiber","year":"2003","unstructured":"Schreiber A et al. (2003) Membrane expression of proteinase 3 is genetically determined. J Am Soc Nephrol 14: 68\u201375","journal-title":"J Am Soc Nephrol"},{"key":"BFncprheum0355_CR27","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1097\/01.ASN.0000028642.26222.00","volume":"13","author":"AA Rarok","year":"2002","unstructured":"Rarok AA et al. (2002) Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis. J Am Soc Nephrol 13: 2232\u20132238","journal-title":"J Am Soc Nephrol"},{"key":"BFncprheum0355_CR28","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1189\/jlb.0604319","volume":"76","author":"AP Van Rossum","year":"2004","unstructured":"Van Rossum AP et al. (2004) Constitutive membrane expression of proteinase 3 and neutrophil activation by anti-PR3 antibodies. J Leukoc Biol 76: 1162\u20131170","journal-title":"J Leukoc Biol"},{"key":"BFncprheum0355_CR29","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1189\/jlb.1102567","volume":"73","author":"D Reumaux","year":"2003","unstructured":"Reumaux D et al. (2003) Expression of myeloperoxidase (MPO) by neutrophils is necessary for their activation by anti-neutrophil cytoplasmic autoantibodies (ANCA) against MPO. J Leukoc Biol 73: 841\u2013849","journal-title":"J Leukoc Biol"},{"key":"BFncprheum0355_CR30","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1182\/blood.V96.8.2822","volume":"96","author":"C Hess","year":"2000","unstructured":"Hess C et al. (2000) Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils. Blood 96: 2822\u20132827","journal-title":"Blood"},{"key":"BFncprheum0355_CR31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1681\/ASN.V12137","volume":"12","author":"R Kettritz","year":"2001","unstructured":"Kettritz R et al. (2001) Role of mitogen-activated protein kinases in activation of human neutrophils by antineutrophil cytoplasmic antibodies. J Am Soc Nephrol 12: 37\u201346","journal-title":"J Am Soc Nephrol"},{"key":"BFncprheum0355_CR32","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/1529-0131(200107)44:7<1698::AID-ART294>3.0.CO;2-J","volume":"44","author":"S Weidner","year":"2001","unstructured":"Weidner S et al. (2001) Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro. Arthritis Rheum 44: 1698\u20131706","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0355_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1046\/j.1365-3083.2003.01209.x","volume":"57","author":"A Wikman","year":"2003","unstructured":"Wikman A et al. (2003) Antineutrophil cytoplasmic antibodies induce decreased CD62L expression and enhanced metabolic activity in monocytes. Scand J Immunol 57: 179\u2013184","journal-title":"Scand J Immunol"},{"key":"BFncprheum0355_CR34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7326\/0003-4819-120-1-199401010-00003","volume":"120","author":"CA Stegeman","year":"1994","unstructured":"Stegeman CA et al. (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120: 12\u201317","journal-title":"Ann Intern Med"},{"key":"BFncprheum0355_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1056\/NEJM199607043350103","volume":"335","author":"CA Stegeman","year":"1996","unstructured":"Stegeman CA et al. (1996) Trimethoprim\u2013sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 335: 16\u201320","journal-title":"N Engl J Med"},{"key":"BFncprheum0355_CR36","first-page":"335","volume":"141","author":"CO Savage","year":"1992","unstructured":"Savage CO et al. (1992) Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 141: 335\u2013342","journal-title":"Am J Pathol"},{"key":"BFncprheum0355_CR37","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1002\/1529-0131(200112)44:12<2851::AID-ART473>3.0.CO;2-2","volume":"44","author":"DJ Radford","year":"2001","unstructured":"Radford DJ et al. (2001) Antineutrophil cytoplasmic antibodies stabilize adhesion and promote migration of flowing neutrophils on endothelial cells. Arthritis Rheum 44: 2851\u20132861","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0355_CR38","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1182\/blood.V82.4.1221.1221","volume":"82","author":"WJ Mayet","year":"1993","unstructured":"Mayet WJ et al. (1993) Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 82: 1221\u20131229","journal-title":"Blood"},{"key":"BFncprheum0355_CR39","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.1365-2249.1999.00799.x","volume":"115","author":"M De Bandt","year":"1999","unstructured":"De Bandt M et al. (1999) Anti-proteinase-3 (PR3) antibodies (C-ANCA) recognize various targets on the human umbilical vein endothelial cell (HUVEC) membrane. Clin Exp Immunol 115: 362\u2013368","journal-title":"Clin Exp Immunol"},{"key":"BFncprheum0355_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1365-2249.1995.tb06642.x","volume":"102","author":"WJ King","year":"1995","unstructured":"King WJ et al. (1995) Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3. Clin Exp Immunol 102: 98\u2013105","journal-title":"Clin Exp Immunol"},{"key":"BFncprheum0355_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2249.2005.02808.x","volume":"141","author":"P Lamprecht","year":"2005","unstructured":"Lamprecht P (2005) Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin Exp Immunol 141: 201\u2013210","journal-title":"Clin Exp Immunol"},{"key":"BFncprheum0355_CR42","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1084\/jem.177.4.905","volume":"177","author":"E Brouwer","year":"1993","unstructured":"Brouwer E et al. (1993) Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med 177: 905\u2013914","journal-title":"J Exp Med"},{"key":"BFncprheum0355_CR43","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1164\/ajrccm.160.3.9807139","volume":"160","author":"P Foucher","year":"1999","unstructured":"Foucher P et al (1999) Antimyeloperoxidase-associated lung disease. An experimental model. Am J Respir Crit Care Med 160: 987\u2013994","journal-title":"Am J Respir Crit Care Med"},{"key":"BFncprheum0355_CR44","first-page":"1695","volume":"149","author":"P Heeringa","year":"1996","unstructured":"Heeringa P et al. (1996) Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol 149: 1695\u20131706","journal-title":"Am J Pathol"},{"key":"BFncprheum0355_CR45","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1172\/JCI0215918","volume":"110","author":"H Xiao","year":"2002","unstructured":"Xiao H et al. (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110: 955\u2013963","journal-title":"J Clin Invest"},{"key":"BFncprheum0355_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0002-9440(10)62952-5","volume":"167","author":"D Huugen","year":"2005","unstructured":"Huugen D et al. (2005) Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-\u03b1. Am J Pathol 167: 47\u201358","journal-title":"Am J Pathol"},{"key":"BFncprheum0355_CR47","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1182\/blood-2005-03-0921","volume":"106","author":"MA Little","year":"2005","unstructured":"Little MA et al. (2005) Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte\u2013microvascular interactions in vivo. Blood 106: 2050\u20132058","journal-title":"Blood"},{"key":"BFncprheum0355_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0002-9440(10)62951-3","volume":"167","author":"H Xiao","year":"2005","unstructured":"Xiao H et al. (2005) The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 167: 39\u201345","journal-title":"Am J Pathol"},{"key":"BFncprheum0355_CR49","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S1081-1206(10)61400-7","volume":"93","author":"PJ Bansal","year":"2004","unstructured":"Bansal PJ and Tobin MC (2004) Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 93: 398\u2013401","journal-title":"Ann Allergy Asthma Immunol"},{"key":"BFncprheum0355_CR50","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1182\/blood-2004-01-0267","volume":"104","author":"H Pfister","year":"2004","unstructured":"Pfister H et al. (2004) Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 104: 1411\u20131418","journal-title":"Blood"},{"key":"BFncprheum0355_CR51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1189\/jlb.69.2.177","volume":"69","author":"YM Van der Geld","year":"2001","unstructured":"Van der Geld YM et al. (2001) Proteinase 3, Wegener's autoantigen: from gene to antigen. J Leukoc Biol 69: 177\u2013190","journal-title":"J Leukoc Biol"},{"key":"BFncprheum0355_CR52","doi-asserted-by":"publisher","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","volume":"116","author":"GS Hoffman","year":"1992","unstructured":"Hoffman GS et al. (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116: 488\u2013498","journal-title":"Ann Intern Med"},{"key":"BFncprheum0355_CR53","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V95842","volume":"9","author":"KW Westman","year":"1998","unstructured":"Westman KW et al. (1998) Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol 9: 842\u2013852","journal-title":"J Am Soc Nephrol"},{"key":"BFncprheum0355_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"D Jayne","year":"2003","unstructured":"Jayne D et al. (2003) European Vasculitis Study Group. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349: 36\u201344","journal-title":"N Engl J Med"},{"key":"BFncprheum0355_CR55","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1056\/NEJM200311203492116","volume":"349","author":"JS Sanders","year":"2003","unstructured":"Sanders JS et al (2003) Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349: 2072\u20132073","journal-title":"N Engl J Med"},{"key":"BFncprheum0355_CR56","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/art.20234","volume":"51","author":"MC Slot","year":"2004","unstructured":"Slot MC et al. (2004) A positive PR3-ANCA titer at switch to azathioprine therapy is associated with a disquieting relapse rate in ANCA-related vasculitis. Arthritis Rheum 51: 269\u2013273","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0355_CR57","first-page":"10","volume":"17","author":"MA Little","year":"2004","unstructured":"Little MA and Pusey CD (2004) Rapidly progressive glomerulonephritis: current and evolving treatment strategies. J Nephrol 17: 10\u201319","journal-title":"J Nephrol"},{"key":"BFncprheum0355_CR58","doi-asserted-by":"crossref","unstructured":"Wegener's Granulomatosis Etanercept Trial (WGET) Research Group (2005) Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 352: 351\u2013361","DOI":"10.1056\/NEJMoa041884"},{"key":"BFncprheum0355_CR59","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1136\/ard.61.6.559","volume":"61","author":"AD Booth","year":"2002","unstructured":"Booth AD (2002) Safety and efficacy of TNF\u03b1 blockade in relapsing vasculitis. Ann Rheum Dis 61: 559","journal-title":"Ann Rheum Dis"},{"key":"BFncprheum0355_CR60","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","volume":"93","author":"DR Jayne","year":"2000","unstructured":"Jayne DR et al. (2000) Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM 93: 433\u2013439","journal-title":"QJM"},{"key":"BFncprheum0355_CR61","doi-asserted-by":"publisher","first-page":"7A","DOI":"10.1681\/ASN.2004110974","volume":"16","author":"K De Groot","year":"2005","unstructured":"De Groot K et al. (2005) European, multicenter randomised controlled trial of daily oral versus pulse cyclophosphamide for induction of remission in ANCA-associated systemic vasculitis [abstract]. J Am Soc Nephrol 16: 7A","journal-title":"J Am Soc Nephrol"},{"key":"BFncprheum0355_CR62","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/art.21142","volume":"52","author":"K De Groot","year":"2005","unstructured":"De Groot K et al. (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52: 2461\u20132469","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0355_CR63","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/art.20718","volume":"52","author":"KA Keogh","year":"2005","unstructured":"Keogh KA et al. (2005) Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52: 262\u2013268","journal-title":"Arthritis Rheum"},{"key":"BFncprheum0355_CR64","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.it.2005.08.010","volume":"26","author":"P Heeringa","year":"2005","unstructured":"Heeringa P et al. (2005) Anti-neutrophil cytoplasmic autoantibodies and leukocyte\u2013endothelial interactions: a sticky connection? Trends Immunol 26: 561\u2013564","journal-title":"Trends Immunol"}],"container-title":["Nature Clinical Practice Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0355","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncprheum0355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T21:01:44Z","timestamp":1684443704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncprheum0355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":64,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["BFncprheum0355"],"URL":"https:\/\/doi.org\/10.1038\/ncprheum0355","relation":{},"ISSN":["1745-8382","1745-8390"],"issn-type":[{"value":"1745-8382","type":"print"},{"value":"1745-8390","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}